MLKL and Hepatic fibrosis: These data suggest that macrophage necroptosis mediated by GDCA/S1PR2/ZBP1/p-MLKL plays a significant role in the pathogenesis of cholestasis-induced liver fibrosis, and may represent a potential therapeutic strategy for BA.